Stay updated on Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; removed the lapse-in-funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA system-wide notice about a lapse in government funding and NIH operating status was added at the top, and the revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedGlossary visibility was added and revision metadata updated to v3.4.0, with the new display of 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' labels; the old 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' labels and revision v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3. This is a minor metadata update with no impact on study content or user actions.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now lists a Locations section with Michigan as a location, and the HHS Vulnerability Disclosure and Michigan Locations entries have been removed. The page revision is updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedEditorial updates to the Publications section add a note that publications are automatically filled from PubMed and update the page revision label to v3.3.2, replacing the previous PubMed wording and the earlier revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.